Head-to-head comparisons of medication uses, side effects, warnings, and more.
Key takeaways
Meloxicam (Mobic) and nabumetone (Relafen) are both prescription NSAIDs used to treat arthritis pain, but they have some differences. Meloxicam is available in multiple forms, including capsules, tablets, oral suspension, and injection, while nabumetone is only available as an oral tablet. Meloxicam tends to block COX-2 more than COX-1, which may result in fewer stomach and kidney side effects compared to other NSAIDs. Nabumetone, on the other hand, is a non-selective COX inhibitor. Both medications can raise the risk of serious side effects like stomach bleeding, heart attack, and kidney problems. Both medications also have potential to cause severe asthma attacks in some people. Additionally, neither is not recommended during late pregnancy, especially after 20 weeks. Both medications should be taken with caution if you have a history of heart, liver, or kidney problems.
Meloxicam
Nabumetone
Meloxicam
Nabumetone
Summary of Meloxicam vs. Relafen
Summary for NSAID
Prescription only
Meloxicam is a prescription non-steroidal anti-inflammatory drug (NSAID) used for different types of arthritis pain. It comes as a capsule, tablet, or liquid that you take by mouth. It's also available as an injection that's given by a healthcare provider in a hospital setting. Common side effects include diarrhea, joint pain, and stomach upset. Like all NSAIDs, meloxicam can raise the risk for stomach bleeds.
Summary for NSAID
Prescription only
Nabumetone is a prescription nonsteroidal anti-inflammatory drug (NSAID). It works to help relieve symptoms of rheumatoid arthritis and osteoarthritis in adults. This can include pain, swelling, and stiffness in your joints. Nabumetone is a tablet that you take by mouth typically once per day. The dosage can be adjusted based on how well the medication is working for you. Side effects can include diarrhea and upset stomach.